Genus Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Sell
48,853
-7,082
-13% -$1.65M 1.22% 23
2026
Q1
$13.7M Buy
55,935
+1,387
+3% +$323K 1.57% 15
2025
Q4
$11.3M Buy
54,548
+43,617
+399% +$8.63M 1.31% 18
2025
Q3
$2.03M Buy
10,931
+9,541
+686% +$1.63M 0.24% 117
2025
Q2
$212K Sell
1,390
-80
-5% -$12.3K 0.03% 174
2025
Q1
$244K Buy
+1,470
New +$230K 0.04% 168
2024
Q2
Sell
-1,830
Closed -$272K 293
2024
Q1
$289K Buy
+1,830
New +$291K 0.04% 176
2023
Q4
Sell
-7,780
Closed -$1.19M 287
2023
Q3
$1.21M Buy
7,780
+5,538
+247% +$914K 0.19% 119
2023
Q2
$371K Buy
+2,242
New +$362K 0.05% 169

Other funds holding JNJ

Genus Capital Management's JNJ Position: Q2 2026 in Review

Genus Capital Management reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $1.65M and leaving 48,853 shares worth $12.4M. The position accounts for 1.22% of the portfolio, ranked #23.

Genus Capital Management first reported a position in JNJ in Q2 2023 and has held it in 9 quarters since. The position peaked at $13.7M in Q1 2026. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Genus Capital Management held 48,853 shares of Johnson & Johnson worth $12.4M as of Q2 2026.
  • Genus Capital Management sold 7,082 Johnson & Johnson shares in Q2 2026, an estimated $1.65M.
  • Johnson & Johnson made up 1.22% of Genus Capital Management's portfolio in Q2 2026, its #23 holding.
  • Genus Capital Management first reported a position in Johnson & Johnson in Q2 2023 and has held it in 9 quarters since.
  • Genus Capital Management's Johnson & Johnson position peaked at $13.7M in Q1 2026.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.